These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37846332)

  • 41. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer.
    Yang J; Eresen A; Shangguan J; Ma Q; Yaghmai V; Zhang Z
    Oncoimmunology; 2021 Feb; 10(1):1875638. PubMed ID: 33643692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
    Sugimoto K; Kakimi K; Takeuchi H; Fujieda N; Saito K; Sato E; Sakamaki K; Moriyasu F; Itoi T
    J Vasc Interv Radiol; 2019 Jun; 30(6):845-853.e6. PubMed ID: 31126596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Irreversible electroporation versus radiofrequency ablation for hepatocellular carcinoma: a single centre propensity-matched comparison.
    Freeman E; Cheung W; Ferdousi S; Kavnoudias H; Majeed A; Kemp W; Roberts SK
    Scand J Gastroenterol; 2021 Aug; 56(8):942-947. PubMed ID: 34057003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
    Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
    Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Irreversible electroporation versus radiofrequency ablation for malignant hepatic tumor: A prospective single-center double-arm trial.
    Liu B; Fu D; Fan Y; Wang Z; Lang X
    J Interv Med; 2022 May; 5(2):89-94. PubMed ID: 35936662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver: follow-up of DCE-MRI and pathological observations.
    Li J; Zhang XB; Wang JJ; Jin LJ; Shan HS; Zhang X; Ma L; Xue XD; Zhang X; Zhang ZL; Meng LL; Yuan F; Xiao YY
    Chin Med J (Engl); 2021 Jun; 134(17):2081-2090. PubMed ID: 34172620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Comparative Study of Ablation Boundary Sharpness After Percutaneous Radiofrequency, Cryo-, Microwave, and Irreversible Electroporation Ablation in Normal Swine Liver and Kidneys.
    Cornelis FH; Durack JC; Kimm SY; Wimmer T; Coleman JA; Solomon SB; Srimathveeravalli G
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1600-1608. PubMed ID: 28516273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible electroporation: ready for prime time?
    Lu DS; Kee ST; Lee EW
    Tech Vasc Interv Radiol; 2013 Dec; 16(4):277-86. PubMed ID: 24238383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
    Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
    Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irreversible Electroporation for the Treatment of Small Renal Masses: 5-Year Outcomes.
    Dai JC; Morgan TN; Steinberg RL; Johnson BA; Garbens A; Cadeddu JA
    J Endourol; 2021 Nov; 35(11):1586-1592. PubMed ID: 33926224
    [No Abstract]   [Full Text] [Related]  

  • 51. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Enlargement of Ablation Area by Electrolytic Irreversible Electroporation (E-IRE) Using Pulsed Field with Bias DC Field.
    Lv Y; Liu H; Feng Z; Zhang J; Chen G; Yao C
    Ann Biomed Eng; 2022 Dec; 50(12):1964-1973. PubMed ID: 35852648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model.
    Bulvik BE; Rozenblum N; Gourevich S; Ahmed M; Andriyanov AV; Galun E; Goldberg SN
    Radiology; 2016 Aug; 280(2):413-24. PubMed ID: 27429143
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison between cryoablation and irreversible electroporation of rabbit livers at a location close to the gallbladder.
    Zeng J; Qin Z; Zhou L; Fang G; Chen J; Li J; Niu L; Liang B; Xu K
    Radiol Oncol; 2017 Mar; 51(1):40-46. PubMed ID: 28265231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Safety of Irreversible Electroporation on Nerves Adjacent to Treated Tumors.
    Luo X; Qin Z; Tao H; Shi J; Fang G; Li Z; Zhou X; Chen J; Xu K; Zeng J; Niu L
    World Neurosurg; 2017 Dec; 108():642-649. PubMed ID: 28927918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
    Marsanic P; Mellano A; Sottile A; De Simone M
    Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irreversible electroporation of the liver and liver hilum in swine.
    Charpentier KP; Wolf F; Noble L; Winn B; Resnick M; Dupuy DE
    HPB (Oxford); 2011 Mar; 13(3):168-73. PubMed ID: 21309933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irreversible electroporation in eradication of rabbit VX2 liver tumor.
    Lee EW; Wong D; Tafti BA; Prieto V; Totonchy M; Hilton J; Dry S; Cho S; Loh CT; Kee ST
    J Vasc Interv Radiol; 2012 Jun; 23(6):833-40. PubMed ID: 22534357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma.
    Wada T; Sugimoto K; Sakamaki K; Takahashi H; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors.
    Babikr F; Wan J; Xu A; Wu Z; Ahmed S; Freywald A; Chibbar R; Wu Y; Moser M; Groot G; Zhang W; Zhang B; Xiang J
    Cell Mol Immunol; 2021 Dec; 18(12):2632-2647. PubMed ID: 34782757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.